Peritoneal dialysis in diabetics: there is room for more
- PMID: 22013524
- PMCID: PMC3195540
- DOI: 10.4061/2011/914849
Peritoneal dialysis in diabetics: there is room for more
Abstract
End stage renal disease diabetic patients suffer from worse clinical outcomes under dialysis-independently of modality. Peritoneal dialysis offers them the advantages of home therapy while sparing their frail vascular capital and preserving residual renal function. Other benefits and potential risks deserve discussion. Predialysis intervention with early nephrology referral, patient education, and multidisciplinary support are recommended. Skilled and updated peritoneal dialysis protocols must be prescribed to assure better survival. Optimized volume control, glucose-sparing peritoneal dialysis regimens, and elective use of icodextrin are key therapy strategies. Nutritional evaluation and support, preferential use of low-glucose degradation products solutions, and prescription of renin-angiotensin-aldosterone system acting drugs should also be part of the panel to improve diabetic care under peritoneal dialysis.
References
-
- Foley RN. Temporal trends in the burden of chronic kidney disease in the United States. Current Opinion in Nephrology and Hypertension. 2010;19(3):273–277. - PubMed
-
- Meyer TW, Hostetter TH. Medical progress: uremia. The New England Journal of Medicine. 2007;357(13):1316–1325. - PubMed
-
- U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in United States. Bethesda, Md, USA: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2010.
LinkOut - more resources
Full Text Sources